A case of breast cancer: Suppression of lactation-related FDG uptake 2 days after cabergoline administration.

IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Hiroyuki Kuroda, Takeshi Yoshizako, Nobuko Yamamoto, Yuko Kataoka, Miki Hyakudomi, Masayuki Itakura, Yasushi Kaji
{"title":"A case of breast cancer: Suppression of lactation-related FDG uptake 2 days after cabergoline administration.","authors":"Hiroyuki Kuroda,&nbsp;Takeshi Yoshizako,&nbsp;Nobuko Yamamoto,&nbsp;Yuko Kataoka,&nbsp;Miki Hyakudomi,&nbsp;Masayuki Itakura,&nbsp;Yasushi Kaji","doi":"10.1177/20584601231174611","DOIUrl":null,"url":null,"abstract":"<p><p>We present a case of a 35-year-old woman with breast cancer in lactation 3 months after childbirth, in which a lactation inhibitor was useful for 18F-FDG PET/CT examination. Via ultrasonography and biopsy with histopathology, we diagnosed the lesion in the upper region of the left breast as invasive ductal carcinoma. She stopped breastfeeding and was administered cabergoline to suppress lactation. Two days after the administration, 18F-FDG PET/CT revealed segmental uptake (10 cm in diameter) and no lactation-related uptakes. Dynamic MRI also revealed a segmental enhancement of the same size as 18F-FDG PET/CT. The lactation inhibitor was useful to delineate the extent of the lesion during the 18F-FDG PET/CT examination.</p>","PeriodicalId":72063,"journal":{"name":"Acta radiologica open","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/75/10.1177_20584601231174611.PMC10164254.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta radiologica open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20584601231174611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

We present a case of a 35-year-old woman with breast cancer in lactation 3 months after childbirth, in which a lactation inhibitor was useful for 18F-FDG PET/CT examination. Via ultrasonography and biopsy with histopathology, we diagnosed the lesion in the upper region of the left breast as invasive ductal carcinoma. She stopped breastfeeding and was administered cabergoline to suppress lactation. Two days after the administration, 18F-FDG PET/CT revealed segmental uptake (10 cm in diameter) and no lactation-related uptakes. Dynamic MRI also revealed a segmental enhancement of the same size as 18F-FDG PET/CT. The lactation inhibitor was useful to delineate the extent of the lesion during the 18F-FDG PET/CT examination.

Abstract Image

Abstract Image

Abstract Image

乳腺癌1例:卡麦角林给药后2天抑制与哺乳期相关的FDG摄取。
我们报告了一例35岁的乳腺癌妇女,在分娩后3个月的哺乳期,泌乳抑制剂对18F-FDG PET/CT检查是有用的。经超声及组织病理学检查,我们诊断为左乳房上部浸润性导管癌。她停止母乳喂养,并给予卡麦角林抑制泌乳。给药两天后,18F-FDG PET/CT显示有节段性摄取(直径10 cm),未见与哺乳期相关的摄取。动态MRI也显示与18F-FDG PET/CT相同大小的节段性增强。在18F-FDG PET/CT检查中,泌乳抑制剂有助于描绘病变范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信